These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16463254)

  • 21. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two blood sampling methods in anticoagulation therapy: venipuncture and peripheral venous catheter.
    Zengin N; Enç N
    J Clin Nurs; 2008 Feb; 17(3):386-93. PubMed ID: 17394539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood sample collection from a peripheral catheter system compared with phlebotomy.
    Seemann S; Reinhardt A
    J Intraven Nurs; 2000; 23(5):290-7. PubMed ID: 11847740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.
    Graham G; Gueorguieva I; Dickens K
    Comput Methods Programs Biomed; 2005 Jun; 78(3):237-49. PubMed ID: 15899308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
    Spooner N; Lad R; Barfield M
    Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods.
    Jaki T; Wolfsegger MJ; Ploner M
    Pharm Stat; 2009; 8(1):12-24. PubMed ID: 18407562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trials.
    Wang DD; Zhang S; Zhao H; Men AY; Parivar K
    J Clin Pharmacol; 2009 Sep; 49(9):1012-24. PubMed ID: 19620385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel system allowing long-term simultaneous video-electroencephalography recording, drug infusion and blood sampling in rats.
    van Raay L; Morris MJ; Reed RC; O'Brien TJ; Dedeurwaerdere S
    J Neurosci Methods; 2009 May; 179(2):184-90. PubMed ID: 19428526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitating pharmacokinetic studies in children: a new use of dried blood spots.
    Patel P; Mulla H; Tanna S; Pandya H
    Arch Dis Child; 2010 Jun; 95(6):484-7. PubMed ID: 20501544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an efficient sampling strategy to predict enoxaparin pharmacokinetics in stage 5 chronic kidney disease.
    Overholser BR; Brophy DF; Sowinski KM
    Ther Drug Monit; 2006 Dec; 28(6):807-12. PubMed ID: 17164698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A note on population pharmacokinetic studies with a single sampling design.
    Narukawa M; Yafune A
    Ther Drug Monit; 2005 Apr; 27(2):111-5. PubMed ID: 15795638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of two sparse sampling population pharmacokinetic approaches for the estimation of pharmacokinetic parameters in children.
    Mahmood I; Tammara V
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):240-5. PubMed ID: 15124982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.
    Schmidli H; Bretz F; Racine-Poon A
    Stat Med; 2007 Nov; 26(27):4925-38. PubMed ID: 17590875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dried blood spots, pharmacokinetic studies and better medicines for children.
    Pandya HC; Spooner N; Mulla H
    Bioanalysis; 2011 Apr; 3(7):779-86. PubMed ID: 21452994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice.
    Clark GT; Haynes JJ; Bayliss MA; Burrows L
    Bioanalysis; 2010 Aug; 2(8):1477-88. PubMed ID: 21083348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling.
    Suyagh M; Collier PS; Millership JS; Iheagwaram G; Millar M; Halliday HL; McElnay JC
    Pediatrics; 2011 Feb; 127(2):e367-74. PubMed ID: 21220396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A composite design for transition from a preliminary to a full-scale study.
    Lachin JM; Younes N
    Stat Med; 2007 Nov; 26(27):5014-32. PubMed ID: 17577245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-simulated effect of errors in infusion duration and blood sampling times on pharmacokinetic calculations for gentamicin.
    Boyce EG; Pugh CB
    Clin Pharm; 1989 Jan; 8(1):48-53. PubMed ID: 2912665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.